Posted by Michael Wonder on 26 Apr 2022
With $35 million in funding, Waltz Health aims to lower drug prices working with – not against – the system
26 April 2022 - After a 30 year career as an executive at some of the country’s largest pharmacy benefit managers – the middlemen that help set drug prices between manufacturers and insurers – Mark Thierer is ready for his next act: helping customers find the lowest prices.
The former CEO of OptumRx insists he doesn’t want to blow up the existing system. But he does want to shine a light on it.
